Official AMFI data
Arthkar — Understand Money, Invest Smartly
Computed from real daily NAV — not projections

₹5,000 Monthly SIP in NIPPON INDIA PHARMA FUND for 10 Years

If you had started a ₹5,000/month SIP on 1 Sept 2016 and never stopped — through every crash and rally — here is exactly what happened, using NIPPON INDIA PHARMA FUND's actual NAV for all 121 installments.

You invested

₹6,05,000

121 installments

Value today

₹16,43,890

1 Sept 2026

Absolute gain

+₹10,38,890

+171.7%

XIRR (annualised)

19.09%

money-weighted

The journey, month by month

Portfolio value Amount invested

Worst fall on the way

-19.5%

Deepest drop from peak. This is what you had to sit through.

Corrections survived

4

Falls of 10%+ during the period. Every one recovered.

Same SIP in a fixed deposit

₹8,39,393

Modelled at historical FD rates. The fund beat FD by ₹8,04,497.

Year-by-year progress

YearInvestedValueOverall gain
Year 1 (1 Sept 2017)₹65,000₹60,777-6.5%
Year 2 (3 Sept 2018)₹1,25,000₹1,49,130+19.3%
Year 3 (3 Sept 2019)₹1,85,000₹1,87,258+1.2%
Year 4 (1 Sept 2020)₹2,45,000₹3,67,779+50.1%
Year 5 (1 Sept 2021)₹3,05,000₹6,14,718+101.5%
Year 6 (1 Sept 2022)₹3,65,000₹5,99,839+64.3%
Year 7 (1 Sept 2023)₹4,25,000₹8,29,063+95.1%
Year 8 (2 Sept 2024)₹4,85,000₹13,26,543+173.5%
Year 9 (1 Sept 2025)₹5,45,000₹13,83,067+153.8%
Year 10 (1 Sept 2026)₹6,05,000₹16,43,890+171.7%

Best year of the journey: Year 8 (+49.2% market move) · Toughest year: Year 6 (-11.1%)

Wealth Time Machine

Watch this exact journey as a 60-second cinematic replay

Every crash headline, every recovery — with your money in it.

Try a different amount

Try a different duration

Same SIP in other Sectoral / Thematic funds

Past performance does not guarantee future returns. This page shows the historical result of the stated SIP using NIPPON INDIA PHARMA FUND's published NAV (source: AMFI) between 1 Sept 2016 and 1 Sept 2026; it is educational research, not investment advice. FD comparison is modelled at historical average FD rates. Mutual fund investments are subject to market risks.